A Spear and Shield-Inspired Ar Plasma Safeguard Few-Layer Black Phosphore with Firefighting of Epoxy Resin.

Appearing as an innovative and efficient strategy, a facile strategy of a plasma ball mill is carried out to prepare few-layer black phosphorus nanosheets (BPNSs), for abating the fire risk of epoxy resin (EP). A spear and shield-inspired Ar plasma emergeed through a plasma ball mill to prevent Ar@BP nanosheets from oxidation compared with the preparation of BP nanosheets (MBPNSs) in a mechanical ball mill. The absorption coefficient in the synchrotron radiation spectrum is increased by 16.91%, indicating that BP is effectively protected by Ar proof. The Vienna ab initio simulation reveals that the combination of Ar@BP with oxygen cannot proceed spontaneously with the binding energy of 4.44 eV. With the introduction of 1.5 wt% Ar@BP, the total heat release (THR), total smoke release (TSR), total smoke production(TSP), CO, and CO2 yield, compared with that of EP, are descended by 30.40%, 24.41%, 24.10%, 33.23%, and 37.60%, respectively, indicating excellent flame retardancy property. It is attributed to the condensed and gas phase function. Meanwhile, the tensile strength and elongation at break increase by 27.92% and 56.04%, respectively, with the incorporation of 1.5 wt% Ar@BP.

Resveratrol ameliorates depressive disorder through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway.

Depressive disorder is a mental health disorder caused by the dysfunction of nerve regeneration, neuroendocrine and neurobiochemistry, which frequently results in cognitive impairments and disorder. Evidence has shown that resveratrol offers benefits for the treatment of depressive disorder. In the present study, the therapeutic effects of resveratrol were investigated and the potential mechanisms mediated by resveratrol were analyzed in hippocampal neuron cells. The anti­oxidative stress and anti­inflammatory properties of resveratrol were also examined in vitro and in vivo. The results revealed that resveratrol administration inhibited the inflammation in hippocampal neuron cells induced by ouabain. Oxidative stress in the hippocampal neuron cells was ameliorated by resveratrol treatment in vitro and in vivo. In addition, the apoptosis of hippocampal neuron cells was inhibited by the upregulation of anti­apoptotic genes, including P53, B­cell lymphoma­2 (Bcl­2) and Bcl­2­associated death promoter, and the downregulation of the cleaved caspase­3 and caspase­9. The analysis of the mechanism revealed that that resveratrol treatment suppressed the apoptosis of hippocampal neuron cells through the NETRIN1­mediated extracellular signal­regulated kinase/cAMP signal transduction pathway. The results of the in vivo assay showed that resveratrol treatment led to improvements in cognitive competence, learning memory ability and anxiety in a mouse model of depressive disorder induced by ouabain. In conclusion, these results indicated that resveratrol treatment had protective effects against oxidative stress and neuroinflammatory pathogenesis through the NETRIN1­mediated extracellular signal­regulated kinase/cAMP signal transduction pathway, suggesting that resveratrol treatment may be a potential antidepressant agent for the treatment of depressive disorder.

Integrated microarray analysis provided novel insights to the pathogenesis of glaucoma.

Glaucoma is characterized as a visual field defect, which is the second most common cause of blindness. The present study performed an integrated analysis of microarray studies of glaucoma derived from Gene Expression Omnibus (GEO). Following the identification of the differentially expressed genes (DEGs) in glaucoma compared with normal control (NC) tissues, the functional annotation, glaucoma­specific protein­protein interaction (PPI) network and transcriptional regulatory network constructions were performed. The acute intraocular pressure (IOP) elevation rat models were established and reverse transcription­quantitative polymerase chain reaction (RT­qPCR) was performed for DEGs expression confirmation. Three datasets were downloaded from GEO. A total of 97 DEGs, 82 upregulated and 15 downregulated were identified in glaucoma compared with NC groups with false discovery rate <0.05. Response to virus and immune response were two significantly enriched GO terms in glaucoma. Valine, leucine and isoleucine degradation was a significantly enriched pathway of DEGs in glaucoma. According to the PPI network, HDAC1, HBN, UBR4 and PDK1 were hub proteins in glaucoma. FOXD3, HNF­4 and AP­1 were the three transcription factors (TFs) derived from top 10 TFs which covered the majority of downstream DEGs in glaucoma. Based on the RT­qPCR results, the expression levels of 3 DEGs, raftlin, lipid raft linker 1 (RFTN1), PBX homeobox 1 (PBX1), HDAC1 were significantly upregulated and the expression of GEM was significantly downregulated in acute IOP elevation rat model at the first and fifth day. These four DEGs had the same expression pattern with our integrated analysis. Therefore, the current study concluded that 6 DEGs, including HEPH, SELENBP1, RFTN1, ID1, HDAC­1 and PBX1 and three TFs, including FOXD3, HNF­4 and AP­1 may be involved with the pathogenesis of glaucoma. The findings of the current study may improve diagnosis and drug design for glaucoma.